A Randomized, sequential, ascending-dose, double blind, placebo-controlled study to investigate pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban administered in healthy Japanese male subjects.

Trial Profile

A Randomized, sequential, ascending-dose, double blind, placebo-controlled study to investigate pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban administered in healthy Japanese male subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 07 May 2014

At a glance

  • Drugs Apixaban (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism; Stroke; Thromboembolism; Venous thromboembolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 May 2014 New trial record
    • 14 Apr 2014 Results published in the International Journal of Clinical Pharmacology and Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top